市場調查報告書

移植的市場規模、佔有率、趨勢分析報告:各產品類型 (組織產品、免疫抑制劑)、用途類型 (器官移植、組織移植)、最終用途、地區的分析,市場區隔預測 (2020-2027年)

Transplantation Market Size, Share & Trends Analysis Report By Product Type (Tissue Products, Immunosuppressive Drugs), By Application Type (Organ, Tissue Transplants), By End Use, And Segment Forecasts, 2020 - 2027

出版商 Grand View Research, Inc. 商品編碼 948102
出版日期 內容資訊 英文 110 Pages
商品交期: 2-3個工作天內
價格
移植的市場規模、佔有率、趨勢分析報告:各產品類型 (組織產品、免疫抑制劑)、用途類型 (器官移植、組織移植)、最終用途、地區的分析,市場區隔預測 (2020-2027年) Transplantation Market Size, Share & Trends Analysis Report By Product Type (Tissue Products, Immunosuppressive Drugs), By Application Type (Organ, Tissue Transplants), By End Use, And Segment Forecasts, 2020 - 2027
出版日期: 2020年06月26日內容資訊: 英文 110 Pages
簡介

全球移植市場規模至2027年預計將達到258億美元,9.3%的年複合成長率。由於器官功能衰竭的病例增加,也提高移植手術的需求。組織產品,免疫抑制劑,及內臟器官保存溶液的需求高漲等要素,預計在預測期間內推動市場成長。因此,許多生物科技及醫療設備製造公司,集中在先進的移植產品的開發。

本報告提供全球移植市場相關調查,目前市場趨勢,各市場區隔、各地區的市場分析與預測,及主要企業簡介等資訊。

第1章 調查手法、範圍

第2章 摘要整理

第3章 移植:市場變數、趨勢、範圍

  • 市場系統預測
  • 滲透率、成長率的展望的製圖
  • 價值鏈分析
  • 市場動態
  • 移植市場分析工具

第4章 移植市場估計&趨勢分析:各產品類型

  • 定義和範圍
    • 組織產品
    • 免疫抑制劑
    • 保存溶液

第5章 移植市場估計&趨勢分析:各用途類型

  • 定義和範圍
    • 器官移植
    • 組織移植
  • 產品的市場佔有率
  • 市場區隔儀表板
  • 全球移植市場:各用途類型的展望
    • 器官移植
    • 組織移植

第6章 移植市場估計&趨勢分析:各最終用途

  • 定義和範圍
    • 醫院
    • 移植中心
    • 其他
  • 產品的市場佔有率
  • 市場區隔儀表板
  • 全球移植市場:各最終用途的展望
    • 醫院
    • 移植中心
    • 其他

第7章 移植市場估計&趨勢分析:各國

  • 市場佔有率分析:各國
  • 各國市場儀表板
  • 地區市場概述
  • 地區的市場佔有率和主要企業
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東、非洲
  • SWOT分析:各因素(政治&法律,經濟及技術)
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東、非洲
  • 市場規模&預測,數量及趨勢分析
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
  • 亞太地區
    • 日本
    • 中國
    • 印度
  • 南美
    • 巴西
    • 墨西哥
  • 中東、非洲
    • 南非
    • 沙烏地阿拉伯

第8章 競爭情形

  • 最近的開發趨勢 & 影響分析:主要的市場參與企業
  • 企業/競爭分類
  • 業者情勢
目錄
Product Code: GVR-1-68038-864-0

Transplantation Market Growth & Trends

The global transplantation market size is expected to reach USD 25.8 billion by 2027, growing at a CAGR of 9.3%, according to a new report by Grand View Research, Inc. Growing cases of organ failure have resulted increased demand for transplantation procedures. Rising demand for tissue products, immunosuppressants, and organ preservation solutions is a major factor anticipated to boost the market growth during forecast period. Thus, many biotechnology and medical device manufacturing companies are concentrating on the development of advanced transplant products.

Technological advancement in organ transplantation methods is another key factor supporting the market growth. Introduction of advanced tissue products, such as DeNovo NT Graft, Chondrofix Osteochondral Allograft, and DuraMatrix Collagen Dura Substitute Membrane provides higher benefits during treatment. In addition, computerized support systems with advanced systems and software allow easy & effective maintenance of tissues. Thus, availability of such advanced techniques supports market growth.

Transplantation Market Report Highlights

Tissue products was the largest revenue-generating segment due to rising demand for tissue and organ transplant procedures

Tissue products segment is expected to expand further at a significant CAGR owing to advancement in transplantation products

The transplant centers end-use segment is projected to register the highest CAGR during the forecast period owing to rising popularity of these centers for transplant procedures

The hospitals segment led the market in 2019, in terms of revenue, owing to a large number of transplant procedures performed in hospitals

North America was the leading regional market in 2019 and is projected to maintain its dominance during the forecast period owing to well-developed healthcare infrastructure

Moreover, presence of a large number of research laboratories, biotechnology, and medical devices manufacturing companies in North America is projected to contribute to the region's growth

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product type
    • 1.1.2. Application type
    • 1.1.3. End use
    • 1.1.4. Region scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product type outlook
    • 2.2.2. Application type outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Transplantation Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Increasing incidence of organ failure
      • 3.4.1.2. Technological advancement in transplantation method
      • 3.4.1.3. Developed tissue banks
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Shortage of organ donors
      • 3.4.2.2. Ethical and cultural issues
    • 3.4.3. Key opportunities prioritized
      • 3.4.3.1. Key opportunities prioritized, by Product
      • 3.4.3.2. Key opportunities prioritized, by application
      • 3.4.3.3. Key opportunities prioritized, by end use
  • 3.5. Transplantation Market Analysis Tools
    • 3.5.1. Industry analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major deals & strategic alliances analysis
    • 3.5.4. Market entry strategies

Chapter 4. Transplantation Market by Product Type Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Tissue products
      • 4.1.1.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
    • 4.1.2. Immunosuppressive drugs
      • 4.1.2.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
    • 4.1.3. Preservation Solutions
      • 4.1.3.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)

Chapter 5. Transplantation Market: Application Type Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Organ transplant
    • 5.1.2. Tissue transplant
  • 5.2. Product Market Share, 2019 & 2027
  • 5.3. Segment Dashboard
  • 5.4. Global Transplantation Market by Application Type Outlook
    • 5.4.1. Organ transplant
      • 5.4.1.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
    • 5.4.2. Tissue transplant
      • 5.4.2.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)

Chapter 6. Transplantation Market: End Use Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Hospitals
    • 6.1.2. Transplantation centers
    • 6.1.3. Others
  • 6.2. Product Market Share, 2019 & 2027
  • 6.3. Segment Dashboard
  • 6.4. Global Transplantation Market by End Use Channel Outlook
    • 6.4.1. Hospitals
      • 6.4.1.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
    • 6.4.2. Transplantation centers
      • 6.4.2.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
    • 6.4.3. Others
      • 6.4.3.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)

Chapter 7. Transplantation Market: Country Estimates & Trend Analysis

  • 7.1. Country Market Share Analysis, 2019 & 2027
  • 7.2. County Market Dashboard
  • 7.3. Regional Market Snapshot
  • 7.4. Regional Market Share and Leading Players, 2019
    • 7.4.1. North America
    • 7.4.2. Europe
    • 7.4.3. Asia Pacific
    • 7.4.4. Latin America
    • 7.4.5. Middle East and Africa
  • 7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 7.5.1. North America
    • 7.5.2. Europe
    • 7.5.3. Asia Pacific
    • 7.5.4. Latin America
    • 7.5.5. Middle East and Africa
  • 7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2019 to 2027:
  • 7.7. North America
    • 7.7.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
    • 7.7.2. U.S.
      • 7.7.2.1. U.S. market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
    • 7.7.3. Canada
      • 7.7.3.1. Canada market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
  • 7.8. Europe
    • 7.8.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
    • 7.8.2. U.K.
      • 7.8.2.1. U.K. market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
    • 7.8.3. Germany
      • 7.8.3.1. Germany market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
    • 7.8.4. France
      • 7.8.4.1. France market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
    • 7.8.5. Italy
      • 7.8.5.1. Italy market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
    • 7.8.6. Spain
      • 7.8.6.1. Spain market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
  • 7.9. Asia Pacific
    • 7.9.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
    • 7.9.2. Japan
      • 7.9.2.1. Japan market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
    • 7.9.3. China
      • 7.9.3.1. China market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
    • 7.9.4. India
      • 7.9.4.1. India market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
  • 7.10. Latin America
    • 7.10.1. market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
    • 7.10.2. Brazil
      • 7.10.2.1. Brazil market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
    • 7.10.3. Mexico
      • 7.10.3.1. Mexico market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
  • 7.11. Middle East & Africa
    • 7.11.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
    • 7.11.2. South Africa
      • 7.11.2.1. South Africa market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
    • 7.11.3. Saudi Arabia
      • 7.11.3.1. South Africa market estimates and forecast, 2016 - 2027 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2019
    • 8.3.4. Stryker Corporation
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Procedure benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Medtronic
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Procedure benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. AbbVie Inc.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Procedure benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Zimmer Biomet
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Procedure benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Novartis
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Procedure benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. 21st Century Medicine
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Procedure benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Biolife Solutions
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Procedure benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Teva Pharmaceutical
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Procedure benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Veloxis Pharmaceuticals
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Procedure benchmarking
      • 8.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America transplantation market, by region, 2026 - 2027 (Revenue, USD Million)
  • Table 3 North America transplantation market, by product type, 2016 - 2027 (Revenue, USD Million)
  • Table 4 North America transplantation market, by application, 2016 - 2027 (Revenue, USD Million)
  • Table 5 North America transplantation market, by end use, 2016 - 2027 (Revenue, USD Million)
  • Table 6 U.S. transplantation market, by product type, 2016 - 2027 (Revenue, USD Million)
  • Table 7 U.S. transplantation market, by application, 2016 - 2027 (Revenue, USD Million)
  • Table 8 U.S. transplantation market, by end use, 2016 - 2027 (Revenue, USD Million)
  • Table 9 Canada transplantation market, by product type, 2016 - 2027 (Revenue, USD Million)
  • Table 10 Canada transplantation market, by application, 2016 - 2027 (Revenue, USD Million)
  • Table 11 Canada transplantation market, by end use, 2016 - 2027 (Revenue, USD Million)
  • Table 12 Europe transplantation market, by region, 2026 - 2027 (Revenue, USD Million)
  • Table 13 Europe transplantation market, by product type, 2016 - 2027 (Revenue, USD Million)
  • Table 14 Europe transplantation market, by application, 2016 - 2027 (Revenue, USD Million)
  • Table 15 Europe transplantation market, by end use, 2016 - 2027 (Revenue, USD Million)
  • Table 16 U.K. transplantation market, by product type, 2016 - 2027 (Revenue, USD Million)
  • Table 17 U.K. transplantation market, by application, 2016 - 2027 (Revenue, USD Million)
  • Table 18 U.K. transplantation market, by end use, 2016 - 2027 (Revenue, USD Million)
  • Table 19 Germany transplantation market, by product type, 2016 - 2027 (Revenue, USD Million)
  • Table 20 Germany transplantation market, by application, 2016 - 2027 (Revenue, USD Million)
  • Table 21 Germany transplantation market, by end use, 2016 - 2027 (Revenue, USD Million)
  • Table 22 France transplantation market, by product type, 2016 - 2027 (Revenue, USD Million)
  • Table 23 France transplantation market, by application, 2016 - 2027 (Revenue, USD Million)
  • Table 24 France transplantation market, by end use, 2016 - 2027 (Revenue, USD Million)
  • Table 25 Italy transplantation market, by product type, 2016 - 2027 (Revenue, USD Million)
  • Table 26 Italy transplantation market, by application, 2016 - 2027 (Revenue, USD Million)
  • Table 27 Italy transplantation market, by end use, 2016 - 2027 (Revenue, USD Million)
  • Table 28 Spain transplantation market, by product type, 2016 - 2027 (Revenue, USD Million)
  • Table 29 Spain transplantation market, by application, 2016 - 2027 (Revenue, USD Million)
  • Table 30 Spain transplantation market, by end use, 2016 - 2027 (Revenue, USD Million)
  • Table 31 Asia Pacific transplantation market, by region, 2016 - 2027 (Revenue, USD Million)
  • Table 32 Asia Pacific transplantation market, by product type, 2016 - 2027 (Revenue, USD Million)
  • Table 33 Asia Pacific transplantation market, by application, 2016 - 2027 (Revenue, USD Million)
  • Table 34 Asia Pacific transplantation market, by end use, 2016 - 2027 (Revenue, USD Million)
  • Table 35 China transplantation market, by product type, 2016 - 2027 (Revenue, USD Million)
  • Table 36 China transplantation market, by application, 2016 - 2027 (Revenue, USD Million)
  • Table 37 China transplantation market, by end use, 2016 - 2027 (Revenue, USD Million)
  • Table 38 Japan transplantation market, by product type, 2016 - 2027 (Revenue, USD Million)
  • Table 39 Japan transplantation market, by application, 2016 - 2027 (Revenue, USD Million)
  • Table 40 Japan transplantation market, by end use, 2016 - 2027 (Revenue, USD Million)
  • Table 41 Latin America transplantation market, by region, 2016 - 2027 (Revenue, USD Million)
  • Table 42 Latin America transplantation market, by product type, 2016 - 2027 (Revenue, USD Million)
  • Table 43 Latin America transplantation market, by application, 2016 - 2027 (Revenue, USD Million)
  • Table 44 Latin America transplantation market, by end use, 2016 - 2027 (Revenue, USD Million)
  • Table 45 Brazil transplantation market, by product type, 2016 - 2027 (Revenue, USD Million)
  • Table 46 Brazil transplantation market, by application, 2016 - 2027 (Revenue, USD Million)
  • Table 47 Brazil transplantation market, by end use, 2016 - 2027 (Revenue, USD Million)
  • Table 48 Mexico transplantation market, by product type, 2016 - 2027 (Revenue, USD Million)
  • Table 49 Mexico transplantation market, by application, 2016 - 2027 (Revenue, USD Million)
  • Table 50 Mexico transplantation market, by end use, 2016 - 2027 (Revenue, USD Million)
  • Table 51 MEA transplantation market, by region, 2016 - 2027 (Revenue, USD Million)
  • Table 52 MEA transplantation market, by product type, 2016 - 2027 (Revenue, USD Million)
  • Table 53 MEA transplantation market, by application, 2016 - 2027 (Revenue, USD Million)
  • Table 54 MEA transplantation market, by end use, 2016 - 2027 (Revenue, USD Million)
  • Table 55 South Africa transplantation market, by product type, 2016 - 2027 (Revenue, USD Million)
  • Table 56 South Africa transplantation market, by application, 2016 - 2027 (Revenue, USD Million)
  • Table 57 South Africa transplantation market, by end use, 2016 - 2027 (Revenue, USD Million)
  • Table 58 Saudi Arabia transplantation market, by product type, 2016 - 2027 (Revenue, USD Million)
  • Table 59 Saudi Arabia transplantation market, by application, 2016 - 2027 (Revenue, USD Million)
  • Table 60 Saudi Arabia transplantation market, by end use, 2016 - 2027 (Revenue, USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Transplantation market, 2018
  • Fig. 14 Transplantation market segmentation
  • Fig. 15 Transplantation market trends
  • Fig. 16 Transplantation market: market driver impact
  • Fig. 17 Transplantation market: market restraint impact
  • Fig. 18 Penetration & growth prospect mapping
  • Fig. 19 Transplantation market- PESTLE Analysis
  • Fig. 20 Industry Analysis - Porter's
  • Fig. 21 Transplantation market competitive landscape: Market position analysis (Based on products, regional presence)
  • Fig. 22 Transplantation market: Product outlook key takeaways
  • Fig. 23 Transplantation market: Product movement analysis
  • Fig. 24 Tissue products market, 2016 - 2027 (Revenue, USD Million)
  • Fig. 25 Immunosuppressive drugs market, 2016 - 2027 (Revenue, USD Million)
  • Fig. 26 Preservation solution market, 2016 - 2027 (Revenue, USD Million)
  • Fig. 27 Transplantation market: Application movement analysis
  • Fig. 28 Transplantation market: 2016 - 2027 (Revenue, USD Million)
  • Fig. 29 Organ transplantation market: 2016 - 2027 (Revenue, USD Million)
  • Fig. 30 Tissue transplantation market: 2016 - 2027 (Revenue, USD Million)
  • Fig. 31 Transplantation market: End use outlook key takeaways
  • Fig. 32 Transplantation market: End use movement analysis
  • Fig. 33 Hospitals market, 2016 - 2027 (Revenue, USD Million)
  • Fig. 34 Transplantation market, 2016 - 2027 (Revenue, USD Million)
  • Fig. 35 Others market, 2016 - 2027 (Revenue, USD Million)
  • Fig. 36 Regional marketplace, 2016 - 2027 (Revenue, USD Million)
  • Fig. 37 North America transplantation market, 2016 - 2027 (Revenue, USD Million)
  • Fig. 38 U.S. transplantation market, 2016 - 2027 (Revenue, USD Million)
  • Fig. 39 Canada transplantation market, 2016 - 2027 (Revenue, USD Million)
  • Fig. 40 Europe transplantation market, 2016 - 2027 (Revenue, USD Million)
  • Fig. 41 U.K. transplantation market, 2016 - 2027 (Revenue, USD Million)
  • Fig. 42 Germany transplantation market, 2016 - 2027 (Revenue, USD Million)
  • Fig. 43 France transplantation market, 2016 - 2027 (Revenue, USD Million)
  • Fig. 44 Italy transplantation market, 2016 - 2027 (Revenue, USD Million)
  • Fig. 45 Spain transplantation market, 2016 - 2027 (Revenue, USD Million)
  • Fig. 46 Asia Pacific transplantation market, 2016 - 2027 (Revenue, USD Million)
  • Fig. 47 Japan transplantation market, 2016 - 2027 (Revenue, USD Million)
  • Fig. 48 China transplantation market, 2016 - 2027 (Revenue, USD Million)
  • Fig. 49 Latin America transplantation market, 2016 - 2027 (Revenue, USD Million)
  • Fig. 50 Brazil transplantation market, 2016 - 2027 (Revenue, USD Million)
  • Fig. 51 Mexico transplantation market, 2016 - 2027 (Revenue, USD Million)
  • Fig. 52 Middle East and Africa i transplantation market, 2016 - 2027 (Revenue, USD Million)
  • Fig. 53 South Africa transplantation market, 2016 - 2027 (Revenue, USD Million)
  • Fig. 54 Saudi Arabia transplantation market, 2016 - 2027 (Revenue, USD Million)